FranceFrance

Bio-people

26.11.2005

Neurotech S.A. (Paris, France) has named Ted Danse as new President and Chief Executive Officer. Danse has a record of more than 25 years in life science industries. He served as President and CEO of the public US ophthalmic pharmaceutical company ISTA Pharmaceuticals Inc. and was Director on the boards of Quest Vision Technologies, Inc. and Vision Solutions Technologies, Inc. Other stations of his carreer include business development roles at Coopervision, Bausch & Lomb, Schering-Plough and Allergan.

FranceFrance

16.09.2010

Marseille – A molecule of the innate immune system controls autoimmunity in mice (JCI, doi: 10.1172/JCI42081). When immunologists from the Centre d‘Immunologie de Marseille-Luminy inactivated the Toll-like receptor 8 (TLR-8),...

FranceFrance

10.09.2010

Paris – Sanofi-Aventis’ pursuit of US-bio­tech company Genzyme was still pending as the French drugmaker entered a strategic alliance for research in personalised medicine with Scripps Genomic Medicine, part of the Scripps Health...

FranceFrance

10.09.2010

Paris – French genome engineering specialist Cellectis SA has purchased all assets of Cyto Pulse Sciences Inc., for US$2m in cash. Celectis’ CEO André Choulika said the acquisition of US-based company specializing in the...

FranceFrance

09.09.2010

Evry – French ophthalmology specialist Novagali Pharma has raised EUR22m in an IPO on the Euronext in Paris and a private placement to institutional investors. The firm, which is located in the Génopôle biocluster in Evry, sold...

FranceFrance

25.08.2010

Paris – French public biotech company BioAlliance Pharma SA has announced the launch of Oravig (marketed as Loramyc in Europe) in the United States by its partner, Strativa Pharmaceuticals, a division of Par Pharmaceutical...

FranceFrance

16.08.2010

Paris - The Haut Conseil des Biotechnologies (HCB), a committee founded in France in 2008, voiced no objection in principle to the cultivation of BASF’s genetically modified potato Amflora. In a statement, the experts said that...

FranceFrance

27.07.2010

Paris-based drug company Sanofi-Aventis appears to be considering spending more than US-$20 billion for Genzyme Corp., the Wall Street Journal reported citing informed circles. This would be the biggest biotech acquisition after...

FranceFrance

23.07.2010

Novagali Pharma, a French pharmaceutical company specialized in ophthalmology, has raised EUR22m in an IPO on Euronext Paris and a private placement to institutional investors. The company, which his located in the Génopôle...

Displaying results 61 to 70 out of 268

< Previous 61-70 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-france/browse/6/article/bio-people-2.html

Events

All Events

Stock list

All quotes

TOP

  • SANTHERA80.00 CHF6.74%
  • WILEX2.26 EUR1.80%
  • ADDEX4.07 CHF1.75%

FLOP

  • MOLOGEN7.30 EUR-6.41%
  • 4SC1.16 EUR-3.33%
  • EVOLVA1.27 CHF-2.31%

TOP

  • SANTHERA80.00 CHF15.4%
  • MAGFORCE6.47 EUR9.7%
  • CYTOS0.27 CHF8.0%

FLOP

  • WILEX2.26 EUR-27.6%
  • MOLOGEN7.30 EUR-22.3%
  • 4SC1.16 EUR-20.0%

TOP

  • SANTHERA80.00 CHF3709.5%
  • CO.DON2.50 EUR228.9%
  • PAION2.41 EUR190.4%

FLOP

  • CYTOS0.27 CHF-93.3%
  • MEDIGENE4.60 EUR-68.1%
  • MERCK KGAA64.23 EUR-45.8%

No liability assumed, Date: 21.08.2014


Current issue

All issues

Product of the week

Products